Alphabet Inc.'s Verily Life Sciences has lost more money than it expected so far this year, which is leading the health care subsidiary to plan for more expense cuts, according to a story in the Wall Street Journal.
Alphabet Inc.'s Verily Life Sciences has lost more money than it expected so far this year, which is leading the health care subsidiary to plan for more expense cuts, according to a story in the Wall Street Journal.
